
AI tailors artificial DNA for future drug development
AI tailors artificial DNA for future drug development With the help of an AI, researchers at Chalmers University of Technology, Sweden, have succeeded in designing…
AI tailors artificial DNA for future drug development With the help of an AI, researchers at Chalmers University of Technology, Sweden, have succeeded in designing…
Remdesivir reduces COVID-19 mortality in a real-world setting The COVID-19 pandemic has led to an explosion of clinical research resulting in the development of a…
Pocket feature shared by deadly coronaviruses could lead to pan-coronavirus antiviral treatment Scientists have discovered why some coronaviruses are more likely to cause severe disease,…
Machine Literacy can help prognosticate patient response to cancer immunotherapy Predicting which cases will respond well to treatment is a double bind that has agonized…
New medicine shows pledge for fighting both COVID- 19 and cancerWhile vaccination can give life- saving protection against COVID- 19, scientists are still searching for…
Making Carcinoma immortal Pitt scientists discover crucial inheritable step in cancer’s race to live ever Scientists at the University of Pittsburgh School of Medicine have…
Imfinzi and Imjudo with chemotherapy approved in the US for cases with metastaticnon-small cell lung cancer blessing grounded on POSEIDON Phase III trial results, which…
COVID vaccination improves effectiveness of cancer treatmentCases with nasopharyngeal cancer are frequently treated with medicines that spark their vulnerable system against the excrescence. Until now,…
Sugar motes as a target in cancer remedyCancer cells use sugar motes on their face to disable attacks by the body’s vulnerable system. Experimenters at…
Study reveals vaccine confidence declined vastly during COVID- 19 epidemicA new study suggests that, despite the success of the COVID- 19 vaccination juggernauts, vaccine confidence…
Farxiga bettered symptom burden and health- related quality of life in cases with mildly reduced or saved ejection bit in DELIVER Phase III trialResults presented…
AMGEN PRESENTS NEW REPATHA ®( EVOLOCUMAB) DATA AT AHA 2022veritably low LDL- C situations< 20 mg/ dL Were Well permitted With no new Safety Signals…